Concepedia

Kaamar Azijli

KA

Statistics

Publications

8

Citations

360

H-Index

8

Active since

2010

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

University Medical Center Groningen

University of Groningen

Vrije Universiteit Amsterdam

Pepscan (Netherlands)

Kaamar Azijli is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in oncology, medicine, and pharmacology.

Publications per year

2010–2016

8

Publications

8

New developments in the treatment of metastatic melanoma: immune checkpoint inhibitors and targeted therapies.

Kaamar Azijli, Ellen Stelloo, Godefridus J. Peters et al. · PubMed · 2014 · 90 citations

, , +17

Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3 dependent invasion in resistant non-small cell lung cancer cells

Kaamar Azijli, Saravanan Yuvaraj, Maikel P. Peppelenbosch et al. · Journal of Cell Science · 2012 · 70 citations · Full text

, , +12

Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib

Kristy J. Gotink, Maria Rovithi, Richard R. de Haas et al. · Cellular Oncology · 2015 · 59 citations · Full text

, , +15

MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1

Kaamar Azijli, Saravanan Yuvaraj, Ingrid van Roosmalen et al. · APOPTOSIS · 2013 · 49 citations

, , +16

Accumulation of thymidine-derived sugars in thymidine phosphorylase overexpressing cells

Irene V. Bijnsdorp, Kaamar Azijli, Erwin E. W. Jansen et al. · Biochemical Pharmacology · 2010 · 33 citations · Full text

, , +9

1–5 of 8